By overcoming the unmet need of well-established or gold standard glycemic index of HbA1c[3], glycated albumin (GA) measurements have been increasingly used as another reliable index for 3-week intermediate glycation monitoring, and GA measurements are further preferred for use in several pathologic conditions, including anemia and chronic kidney disease (CKD) [5]–[7]. This evidence concerns the gene ALB and chronic kidney disease.